These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Regional immunotherapy in resectable squamous cell lung carcinoma. Analysis of a randomized study.
    Author: Roeslin N, Lang JM, Morand G, Wihlm JM, Witz JP.
    Journal: Cancer Immunol Immunother; 1982; 13(3):174-5. PubMed ID: 6925982.
    Abstract:
    Patients with resectable squamous cell carcinoma were randomly allocated after surgery to receive either no further treatment (57 patients) or a single intrapleural injection of BCG (61 patients). No significant improvement in survival was observed in patients treated with BCG, even when their disease was staged as N0. There was a slight trend for the recurrence rate to be lower in patients classed as N0, but this was not significant.
    [Abstract] [Full Text] [Related] [New Search]